Neonatal caffeine exposure alters seizure susceptibility in rats in an age-related manner.
Early developmental exposure to caffeine in rats results in decreased susceptibility to certain chemically-induced seizures in the adult. To determine whether this effect first appears in adulthood or is present during preceding developmental stages, we exposed neonatal rats to caffeine and determined seizure thresholds in animals 28, 42 and 70-90 days of age. Rats were unhandled or received either vehicle (water) or caffeine (15-20 mg/kg/day) by gavage (0.05 ml/10 g) over postnatal days 2-6. At 28, 42, or 70-90 days of age, rats were infused intravenously with picrotoxin (PIC), bicuculline (BIC), pentylenetetrazol (PTZ), caffeine (CAFF), strychnine (STR), or kainic acid (KA). Seizure thresholds for each compound were analyzed as a function of neonatal treatment, sex, and age. At 28 days, neonatally caffeine-exposed rats had a higher seizure threshold only for PTZ (P < 0.03). At 42 days, neonatally caffeine-exposed rats had higher seizure thresholds for PIC (P < 0.0007) and PTZ (P < 0.0001) than did controls. These results at 28 and 42 days are compared with previously reported data that demonstrated that in adulthood, rats neonatally exposed to caffeine have higher thresholds for seizure induction with CAFF, PTZ, and KA. Thus, early developmental exposure to caffeine results in decreases in seizure susceptibility that are agent specific and may result in a delay in the decrease in seizure threshold that occurs for many agents between late juvenile ages and adulthood.
Guillet
R
R
Department of Pediatrics (Neonatology), Strong Children's Medical Center, University of Rochester School of Medicine and Dentistry, NY 14642, USA.
D000375:Aging; D000704:Analysis of Variance; D000818:Animals; D000831:Animals, Newborn; D002110:Caffeine / Q000633:toxicity*; D003292:Convulsants / Q000633:toxicity; D004198:Disease Susceptibility; D005260:Female; D008297:Male; D051381:Rats; D012640:Seizures / Q000139:chemically induced*; D012727:Sex Characteristics
D003292:Convulsants; D002110:Caffeine